December 23, 2025

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Deep Dive into Its 87% Potential Upside

Investors tracking the biotechnology sector may want to pay close attention to Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage company dedicated to advancing treatment options for neuromuscular diseases. With a..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Biotech with 57% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing the attention of investors with its promising pipeline and substantial upside potential. Operating in the dynamic biotechnology sector, this clinical-stage global biopharmaceutical company..

NewAmsterdam Pharma (NAMS) Stock Analysis: Biotech Giant with 31% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a key player in the healthcare sector with a specialization in biotechnology, has been making waves in the investment world. This Netherlands-based company, with..

DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Exploring a 13.38% Upside Potential Amidst Challenging Metrics

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, is renowned for its innovative dental solutions and equipment. With a market capitalization of $2.25 billion, this Charlotte,..

Novavax, Inc. (NVAX) Stock Analysis: Unveiling an 85% Upside Potential in the Biotech Sector

In the dynamic world of biotechnology, Novavax, Inc. (NASDAQ: NVAX) stands out as a company with intriguing potential despite recent challenges. With a market capitalization of $1.12 billion and a..

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a Potential 72% Upside in the Healthcare Sector

Dynavax Technologies Corporation (NASDAQ: DVAX) is drawing investor attention with its promising growth prospects in the healthcare sector. As a commercial-stage biopharmaceutical company, Dynavax is focused on the development and..

Harrow, Inc. (HROW) Stock Analysis: Healthcare Potential with 43% Upside

Harrow, Inc. (NASDAQ: HROW), a Nashville-based eyecare pharmaceutical company, has been making waves in the healthcare sector, with a particular focus on ophthalmic pharmaceutical products. The company’s recent transition from..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with a 7.46% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a significant player in the U.S. healthcare sector, operates within the medical care facilities industry. With a market capitalization of $2.56 billion, Brookdale is..

Vericel Corporation (VCEL) Stock Analysis: A 47% Upside Potential Beckons Investors

Vericel Corporation (NASDAQ: VCEL) presents an intriguing opportunity for investors seeking growth in the healthcare sector. With a market capitalization of $1.89 billion, this biotechnology firm is making significant strides..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 62.58% Upside Potential

Investors with a keen eye on the healthcare sector, particularly the biotechnology industry, may find Innoviva, Inc. (NASDAQ: INVA) a compelling opportunity. This U.S.-based company, with a market cap of..

Organon & Co. (OGN) Stock Analysis: Exploring the 34% Potential Upside Amidst a Mixed Market Sentiment

For investors keen on healthcare stocks, Organon & Co. (NYSE: OGN) presents a fascinating case. This pharmaceutical company, with a market cap of $1.81 billion, operates in the general drug..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 14.2% Potential Upside in Specialty Pharmaceuticals

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands as a notable player in the healthcare sector, specializing in non-opioid pain management solutions. Headquartered in Tampa, Florida, the company is engaged in the..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Unveiling a 170% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a notable player in the healthcare sector, specializes in developing innovative treatments for rare diseases. With a market capitalization of $1.6 billion, this Durham, North..

MannKind Corporation (MNKD) Stock Analysis: A Biotech with 60% Upside Potential

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, is garnering significant attention from investors due to its promising growth prospects. With a market capitalization of $1.84 billion,..

AtriCure, Inc. (ATRC) Investor Outlook: Evaluating a 25.65% Upside Potential with Strong Buy Ratings

AtriCure, Inc. (ATRC), a prominent player in the medical instruments and supplies industry, is capturing attention with its strong growth metrics and compelling analyst ratings. Headquartered in Mason, Ohio, AtriCure..

LivaNova PLC (LIVN) Stock Analysis: Exploring a Robust 12% Potential Upside in the Medical Device Sector

Investors eyeing opportunities in the healthcare sector may find LivaNova PLC (NASDAQ: LIVN) an intriguing prospect. This UK-based medical device company, with a market capitalization of $3.44 billion, is making..

ICU Medical, Inc. (ICUI) Stock Analysis: Potential 21.91% Upside with Strong Buy Ratings

Investors seeking opportunities in the healthcare sector may find ICU Medical, Inc. (NASDAQ: ICUI) a compelling choice, given its robust potential upside and solid analyst ratings. The company, specializing in..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 30% Potential Upside Amid Robust Revenue Growth

U.S. Physical Therapy, Inc. (NYSE: USPH) is a notable player in the healthcare sector, specifically within the medical care facilities industry. Based in Houston, Texas, this company is distinguished by..

Phreesia, Inc. (PHR) Stock Analysis: A Potential 81% Upside with Strong Buy Consensus

Phreesia, Inc. (PHR) is making waves in the healthcare sector, specifically within the health information services industry. With a market capitalization nearing the billion-dollar mark at $992.93 million, Phreesia is..

Search

Funds

December 23, 2025

Search

Funds

December 23, 2025

FTSE 100

Funds